Clinical Characteristics and Implications of Bradycardia in COVID-19 Patients Treated with Remdesivir: A Single-Center Retrospective Cohort Study

BACKGROUND AND OBJECTIVES: Remdesivir is an antiviral drug used to treat coronavirus disease 2019 (COVID-19) with a relatively obscure cardiac effect profile. Previous studies have reported bradycardia associated with remdesivir, but few have examined its clinical characteristics. The objective of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Schreiber, Ariyon, Bauzon, Justin S., Batra, Kavita, Mohammed, Salman, Lee, Kevin, Houshmand, Nazanin, Pham, Uyen, Cosme, Celica, Inciong, Kim, Al-Taweel, Omar, Nasser, Keaton, Rana, Jibran, Sossou, Chris, Go, Ariel, Hawwass, Dalia, Diep, Jimmy, Ahsan, Chowdhury H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9385079/
https://www.ncbi.nlm.nih.gov/pubmed/35978159
http://dx.doi.org/10.1007/s40261-022-01187-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9385079/
https://www.ncbi.nlm.nih.gov/pubmed/35978159
http://dx.doi.org/10.1007/s40261-022-01187-x

Ejemplares similares